UK researchers publish further evidence highlighting the need to licence pimavanserin for hallucinations and delusions in Parkinson's.

New research suggests that a type of asthma drug that activates a protein called beta-adrenoceptors, may decrease risk of Parkinson's. 

Results published today make significant strides into our understanding of cell transplants for Parkinson's.

UK researchers have shared promising results of a phase 2 clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's.

New research, reported in the scientific journal Nature, suggests that the immune system plays an important role in the progression of Parkinson's.

Higher consumption of low fat dairy products such as milk, butter, cheese and yoghurt is linked to a modest increase in risk of Parkinson’s, according to new research. 

Scientists have developed a new technique that shows promise as a non-invasive approach to deep brain stimulation.

New research shows promise for repurposed drugs that slow dementia.

New research published in Nature Biotechnology shows that it may be possible to reprogramme cells inside the brain to reverse the symptoms of Parkinson's.

Research suggests there may be a link between hepatitis infection and an increased risk of developing Parkinson's.